Information Provided By:
Fly News Breaks for April 5, 2017
IPXL
Apr 5, 2017 | 06:53 EDT
Deutsche Bank analyst Gregg Gilbert raised his price target for Impax Laboratories to $15 from $11 on optimism that new CEO Paul Bisaro can set the company on the path to value creation. Making Impax more efficient and profitable will be one key near-term objective, Gilbert tells investors in a research note. The analyst says his new target assumes Impax will reduce operating expenses. He keeps a Buy rating on the shares.
News For IPXL From the Last 2 Days
There are no results for your query IPXL